india glp-1 India's weight-loss drug rush kicks off with generics 50-90% cheaper Inside OneSource: India’s Next Big
Description
The FDA prescribing information for these agents lists common adverse effects including nausea, vomiting, diarrhea, constipation, and abdominal pain, but does not include blood clots among recognized risks

As a result, there is a potential 5-plus year window of uncertainty before the cost-benefit uncertainty is effectively settled
)
The psychological distress associated with constant food preoccupation can also contribute to feelings of guilt, shame, and reduced self-efficacy regarding dietary management

Allegations of Undisclosed Risks Plaintiffs assert that the manufacturers of Ozempic, Wegovy, Mounjaro, Victoza, Saxenda, Rybelsus, and other GLP-1 agonists failed to adequately warn consumers about the risk of these potentially life-altering side effects

Many hypothalamic neurons are specialized in the secretion of neuropeptides involved in regulating the neuroendocrine axis, modulating the pituitarys hormonal secretion
